Health-care utilization, costs, and quality of life in patients with sepsis: Results from the SAGA trial in the Netherlands

BACKGROUND: Sepsis imposes a substantial clinical and economic burden, yet detailed patient-level data on long-term healthcare costs and quality of life (QoL) is mainly based on intensive care unit (ICU) survivors and relies on model-based projections for patients treated in general wards. AIM: To assess direct and indirect healthcare costs and QoL during the first year after community-onset sepsis. METHODS: Data were obtained from a cluster-randomized trial of patients hospitalized with sepsis of urological, abdominal or unknown origin in the Netherlands. Mean direct hospitalization costs were collected from hospital data. Additional healthcare utilization and productivity losses were obtained through structured questionnaires in a subset of patients followed for 12 months. We used inverse probability weighting to adjust for differences between the subset and full cohort. QALYs were estimated using the EQ-5D-5L at months 0 (then-test), 2, 6, and 12, and the SF-36 was administered at 12 months. RESULTS: Among 472 patients, 91 (19%) required ICU admission. Mean direct hospitalization costs were €8858 (95% CI: 7988-9855) per patient: €6697 (95% CI: 6185-7251) for general ward-admitted patients and €18,155 (95% CI: 14,856-22,342) for ICU-admitted patients. Over 12 months, mean total costs per patient were €30,889 (95% CI: 22,485-43,105): €25,839 (95% CI: 19,089-35,845) for general ward-admitted patients and €41,769 (95% CI: 23,132-48,943) for ICU-admitted patients. The weighted mean QALY during follow-up was 0.62 (95% CI: 0.51-0.74) compared with 0.65 (95% CI: 0.54-0.75) before sepsis. SF-36 at 12 months showed the greatest limitations in general health, physical role functioning, and energy/fatigue. CONCLUSION: Sepsis is followed by substantial healthcare and societal costs during the first year after admission, with a significant burden among patient treated in general wards. By providing Dutch patient-level cost and QoL data across ICU and non-ICU settings, this study enables improved economic evaluations and better-informed health policy. TRIAL REGISTRATION: European Union Clinical Trials Register (2021-001,840-83). Count = 296.

Authors

Institutions

Publication Details

Journal
Journal of Critical Care
Published
2026-11-17
DOI
https://doi.org/10.1016/j.jcrc.2026.155830
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Health-care utilization, costs, and quality of life in patients with sepsis: Results from the SAGA trial in the Netherlands

Paul D. van der Linden, Cornelis H. van Werkhoven, Jan Jelrik Oosterheert, Jan M. Prins et al.
Journal of Critical Care
Sepsis Diagnosis and Treatment
article

Health-care utilization, costs, and quality of life in patients with sepsis: Results from the SAGA trial in the Netherlands

Paul D. van der Linden, Cornelis H. van Werkhoven, Jan Jelrik Oosterheert, Jan M. Prins, Marc J. M. Bonten, Eva L. Koekenbier, Hjalmar R. Bouma, Anthonius S. M. Dofferhoff, Sharon E.J.D. van den Eijnde, H.S.M. Ammerlaan, L.M. Kampschreur, E. Jong, M. Gompelman
article en

Abstract

BACKGROUND: Sepsis imposes a substantial clinical and economic burden, yet detailed patient-level data on long-term healthcare costs and quality of life (QoL) is mainly based on intensive care unit (ICU) survivors and relies on model-based projections for patients treated in general wards. AIM: To assess direct and indirect healthcare costs and QoL during the first year after community-onset sepsis. METHODS: Data were obtained from a cluster-randomized trial of patients hospitalized with sepsis of urological, abdominal or unknown origin in the Netherlands. Mean direct hospitalization costs were collected from hospital data. Additional healthcare utilization and productivity losses were obtained through structured questionnaires in a subset of patients followed for 12 months. We used inverse probability weighting to adjust for differences between the subset and full cohort. QALYs were estimated using the EQ-5D-5L at months 0 (then-test), 2, 6, and 12, and the SF-36 was administered at 12 months. RESULTS: Among 472 patients, 91 (19%) required ICU admission. Mean direct hospitalization costs were €8858 (95% CI: 7988-9855) per patient: €6697 (95% CI: 6185-7251) for general ward-admitted patients and €18,155 (95% CI: 14,856-22,342) for ICU-admitted patients. Over 12 months, mean total costs per patient were €30,889 (95% CI: 22,485-43,105): €25,839 (95% CI: 19,089-35,845) for general ward-admitted patients and €41,769 (95% CI: 23,132-48,943) for ICU-admitted patients. The weighted mean QALY during follow-up was 0.62 (95% CI: 0.51-0.74) compared with 0.65 (95% CI: 0.54-0.75) before sepsis. SF-36 at 12 months showed the greatest limitations in general health, physical role functioning, and energy/fatigue. CONCLUSION: Sepsis is followed by substantial healthcare and societal costs during the first year after admission, with a significant burden among patient treated in general wards. By providing Dutch patient-level cost and QoL data across ICU and non-ICU settings, this study enables improved economic evaluations and better-informed health policy. TRIAL REGISTRATION: European Union Clinical Trials Register (2021-001,840-83). Count = 296.

Journal of Critical CareVol. 97
Medisch Centrum Leeuwarden (NL), University Medical Center Utrecht (NL), Elkerliek Ziekenhuis (NL), Tergooi (NL), Amsterdam University Medical Centers (NL), Meander Medisch Centrum (NL), University of Amsterdam (NL)
ZonMw
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon